arrow
A

Arend Mosterd

mcmaster university
H指数:47
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial

螺内酯在轻度射血分数降低或保留的心力衰竭治疗中的应用:SPIRIT-HF-DZHK08试验的设计和基线特征

2026-07-280
OAAI
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial

低剂量地高辛在射血分数降低或轻度降低的心力衰竭患者中的应用:一项随机对照试验

2026-05-100
OAAI
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial

秋水仙碱和克隆性造血的纵向动力学:LoDoCo2试验的一项探索性亚组研究

JACC
IF0
2025-08-290
OAAI
Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort

白细胞介素-6修饰与脂蛋白(a)和氧化磷脂相关的心血管疾病风险,在一个二级预防队列中。

2025-06-010
PRE
Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial

低剂量秋水仙碱对慢性冠状动脉疾病患者冠脉周围炎症及冠状动脉斑块组成的影响:LoDoCo2试验的亚组分析

HEART
IF4.4
2025-05-190
PRE
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials

秋水仙碱用于缺血性卒中和动脉粥样硬化事件的二级预防: 随机试验的荟萃分析

2024-10-011
OAAI
Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial

小剂量地高辛对心力衰竭患者的疗效和安全性。判决审判的理论基础和设计

2024-08-300
OA
Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study
2024-06-022
OAAI
Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study

新的,慢性的和恶化的心力衰竭患者的当代指南指导的药物治疗: 来自TITRATE-HF研究的第一个数据

2024-05-123
OA
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial
2024-05-113
OAAI